WNT10B protein expression was more highly expressed in TNBC (80%) compared to other subtypes of breast cancer (10% in ER+/Her2+/PR+) and significantly predicted worse survival outcomes, tumor size, and grade, suggesting, for the first time, that WNT10B expression is clinically relevant in breast cancer. Here, WNT10B is linked to neoplasm.